Almac has created a new non-GMP formulation development facility and two new analytical laboratories at their U.K. headquarters in Craigavon to expand its drug product pharmaceutical development ...
Following the success of one of its key client partnered products, Craigavon-based pharmaceutical company Almac, has announced the commercial manufacturing expansion. Together with the recent ...
Firm will initially construct new non-GMP formulation development suite and then add new QC laboratories. Contract research and development firm Almac is to invest £4.5 million into the first phase of ...
To win at the drug development game, it’s not enough to show up with a great molecule. Many compounds would stall at the discovery stage without effective ways to get them inside patients. But the ...
When AstraZeneca ($AZN) abandoned its campus in Charnwood in the U.K. some years back, it left new owners to figure out what would be done with the facilities. Now ...
PARSIPPANY, N.J., -- DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it has signed a collaboration agreement ...
TAIPEI, May 6, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Almac Discovery, a ...
CARY, N.C. & SOUDERTON, Pa.--(BUSINESS WIRE)--THREAD, a technology and service provider enabling decentralized clinical trials (DCTs), and Almac Clinical Technologies, a member of the contract and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results